Search results “Tumor board and national cancer registry”
MedStar Harbor Hospital's Cancer Registrar Coordinator
Take a look into Pamela Trombero's daily work routine as a Cancer Registrar Coordinator at MedStar Harbor Hospital. Learn more about Lung Cancer at MedStar Harbor Hospital here: http://bit.ly/1MViJ4Q
Views: 415 MedStar Health
Cancer Registrars Now Is The Time
Cancer Registrars have the opportunity and ability to SEE into their future and bring hope, achievement and success not only to themselves, but to everyone on their team. How do you see your future?
Views: 2056 CancerRegistrar
Cancer Registrar Evidence Based Medicine
Cancer Registrars collect and provide high quality data used to develop clinical practice guidelines in evidence-based medicine. Changes in science and medicine drive reciprocal changes in the cancer registry and recent advances have changed the face of the cancer registrar's future and role in medicine.
Views: 1092 CancerRegistrar
Panc MD - Pancreas Cancer & Genetics
Meet Alison Klein, Director of the National Familial Pancreas Tumor Registry at Johns Hopkins. She will discusses the role of genetics in pancreatic cancer.
Views: 1455 Johns Hopkins Kimmel
Grade Path Value and System
In this video for cancer registrars, AJCC's Donna Gress explains how to document the Grade Path Value and the Grade Path System in the registry database. Learn more at http://cancerstaging.org. This presentation was supported by the Cooperative Agreement Number 5U58DP001864-04 from The Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of The Centers for Disease Control and Prevention.
Views: 2474 AJCCancer
Reprogramming the Immune System to Fight Cancer
Speaker: PD Dr. med. Jens Hasskarl, Hematologist, Oncologist, Global Clinical Leader CTL019 Novartis Pharma AG, Basel (CH) "Pushing the Limits in Novel Medicine ‐ Gene Transfer, Cells, Targeting, Materials" Chair Dr. med. h.c. Beat Löffler, MA, European Foundation for Clinical Nanomedicine, Basel (CH) and Prof. Dr. Lajos P. Balogh, Editor‐in‐Chief, Nanomedicine, Nanotechnology, Biology and Medicine, Elsevier and Member of the Executive Board, American Society for Nanomedicine, Boston (USA)) Day 2 Hall Montreal CLINAM 2015 The European Summit for Clinical Nanomedicine and Targeted Medicine – The Translation to Knowledge Based Medicine Eighth Conference and Exhibition, June 30 2015
Views: 402 TAUVOD
Exploring a new model for occupational cancer surveillance, October 7, 2014
There are about 60 well-established workplace carcinogens, and still more to-be-identified occupational carcinogens. Yet Canada still lacks a rapid, systematic means to assess increased cancer risk associated with occupational exposures. Although Canada collects timely and high quality information on every new cancer that is diagnosed through provincial and national registries, occupational cancer surveillance data has been limited by the lack of information on industry and occupation. In a pilot study, a research team linked Workplace Insurance and Safety Board (WSIB) lost-time claims data with the Ontario Cancer Registry (OCR). In this plenary, Dr. Paul Demers, director of the Occupational Cancer Research Centre, discusses the results of the pilot study, focusing on the feasibility of this new approach to assessing and monitoring workplace risk factors for cancer.
Views: 141 IWH Research
NCI Cancer Research Data Commons
Presentation given by Allen Dearry, Program Director, NIH, on the National Cancer Institute (NCI) Cancer Research Data Commons, at Big Data IWG meeting on 06/28/2018. Presentation outline: "National Cancer Data Ecosystem; NCI Cancer Research Data Commons; Data Linkages: Cancer Data Aggregator, Encrypted Unique Patient Identifier; Collaboration/coordination: Partnerships, Office of Data Sharing."
Views: 69 NITRD Program
Medical Radiation and cancer risk: assessing the price of progress
Medical Radiation and cancer risk: assessing the price of progress Air date: Friday, January 11, 2013, 12:00:00 PM Category: NIH Director's Seminars Runtime: 01:02:02 Description: NIH Director's Seminar Radiation exposure to the US population from diagnostic imaging has increased 6-fold in the last three decades, primarily due to the rapid increase in CT scans from 1 to 80 million per year. Despite the great medical benefits there are concerns about the potential future cancer risks from CT and other higher dose imaging tests such as nuclear medicine cardiac stress tests. Dr. Berrington's Radiation Epidemiology Branch conducted the first study to directly assess the cancer risks after CT scans in a historical cohort study of 200,000 children in the UK. Dr. Berrington will discuss the first results from this study and also present risk projections for the number of future cancers in the US that may be related to diagnostic imaging in children and adults if use continues at current levels. Recently a number of new screening tests such as lung CT and CT colonography have been proposed for use in the general population, and newer radiotherapy techniques like proton therapy have become more widespread. Dr. Berrington will also describe work that she has conducted that assesses the balance of the potential benefits against the radiation-related cancer risks for these emerging technologies. Permanent link: https://videocast.nih.gov/launch.asp?17744
Views: 483 nihvcast
We Were There - PVC and Angiosarcoma
"We Were There" lecture series' latest lecture video titled "How a Rare Cancer Changed the Workplace and Environment - PVC and Angiosarcoma" Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://www.cdc.gov/video/WWT_PVC/WWT-Rare_Cancer_04-24-2018_LowRes.mp4
Anne LanierAnne P. (Pelizzoni) Lanier, M.D.
As a family practice physician, medical epidemiologist, researcher and administrator, Anne Lanier has worked to improve health among Alaska’s Native people since 1967. Starting as a physician at the Alaska Native Medical Center, she saw too many young Alaska Native people dying of cancer. She asked why and, finding no answers, she determined to seek them. In 1974 Lanier created the Alaska Native Tumor Registry, one of 18 National Cancer Institute’s Surveillance Epidemiology and End Results registries, to determine cancer rates and patterns throughout the U.S. Her data-driven research has led to dramatic declines in incidence and mortality rates in pediatric liver and cervical cancer among Alaska’s Native people. She always published her data so others could review her conclusions. Lanier was the first female director of the Centers for Disease Control and Prevention’s Arctic Investigations Program. She initiated the Alaska Native Epidemiology Center and later created the Alaska Native Health Consortium’s Office of Alaska Native Health Research. Lanier currently is a consultant for the Alaska Native Tribal Health Consortium in Anchorage. In 1982 Lanier became a Fellow of the American Board of Preventative Medicine. In 2011 she received the inaugural Carol Frieden Award for Extraordinary Leadership in Comprehensive Cancer Control from the Centers for Disease Control and Prevention. After graduating from Lawrence University in Appleton, Wis., in 1962, Lanier earned her M.D. degree from Washington University School of Medicine in 1966 and completed a Masters of Public Health degree at the University of Minnesota School of Public Health in 1975. She did an internship at Presbyterian Hospital in Denver, Colo., before taking her first job in Alaska. Lanier has three children and five grandchildren. She is a reader, skier, kayaker, and traveler. She has mentored several generations of health researchers and personally funds a scholarship at the University of Alaska Anchorage for those pursuing master’s degrees in public health.
Cancer Epidemiology over the Last Half-Century and Thoughts on the Future
In May 2012, NCI's Division of Cancer Epidemiology and Genetics (DCEG) welcomed David Schottenfeld, M.D. as a Visiting Scholar. Dr. Schottenfeld is the John G. Searle Professor Emeritus of Epidemiology at the University of Michigan School of Public Health and Professor Emeritus of Internal Medicine at the University of Michigan Medical School. He has collaborated with several investigators in DCEG, particularly, Joseph F. Fraumeni, Jr., M.D., Senior Investigator and Advisor to NCI, NIH and Former Division Director of DCEG. Drs. Fraumeni and Schottenfeld each have over fifty years of experience in the field of epidemiology, and they have co-edited the definitive textbook Cancer Epidemiology and Prevention. During this special visit, they participated in a panel discussion, moderated by Robert N. Hoover, M.D., Sc.D., Director of the Epidemiology and Biostatistics Program in DCEG, on "Cancer Epidemiology over the Last Half-Century and Thoughts on the Future". The discussion focused on their personal reflections about their past mentors and colleagues, noteworthy contributions to the field, and how cancer epidemiology has evolved as a discipline. To view highlights from the discussion, visit: http://dceg.cancer.gov/fraumeni-schottenfeld-video
Views: 591 NCIwebinars
Li-Fraumeni Syndrome: Discovery and Future Challenges
In May 2014, NCI’s Division of Cancer Epidemiology and Genetics (DCEG) hosted “Cancer Epidemiology: From Pedigrees to Populations,” a scientific symposium honoring 50 years of visionary leadership by Dr. Joseph F. Fraumeni, Jr., the founding Director of DCEG. In this video, Dr. Stephen Chanock of NCI provides opening remarks. Dr. David Schottenfeld of the University of Michigan moderates a session on the search for cancer susceptibility genes. Dr. Louise Strong of University of Texas MD Anderson Cancer Center speaks about the discovery and future challenges of Li-Fraumeni syndrome research. For more information on this symposium, visit http://dceg.cancer.gov/news-events/Fraumeni-symposium-speakers
The Lung Cancer Living Room™ - Patient Registry - March 21, 2017 - Half-hour Episode
Join Kyle Brown of Invitae, as he discusses the importance of creating an online patient profile. By registering on lungcancerregistry.org, lung cancer patients can contribute to a growing collection of data that drives important decisions in the medical arena.
"Graft-Versus-Host Disease" by Christine Duncan for OPENPediatrics
Please visit: www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu Please note: OPENPediatrics does not support nor control any related videos in the sidebar, these are placed by Youtube. We apologize for any inconvenience this may cause.
Views: 5709 OPENPediatrics
Cancer and Family History: Using Genomics for Prevention
The risk factors for cancer are many and varied, and inherited genetic mutations play a major role in 5 to 10% of all cancers. When these mutations are identified early, patients are able to work with their healthcare providers to take crucial steps toward care and treatment. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at https://www.cdc.gov/video/phgr/2016/GR_04-19-2016-lo-res.mp4
Cancer Risk in NF1
Speaker: Dave Viskochil, MD, PhD, University of Utah This is an original presentation from the 2018 NF Forum that took place in Atlanta, Georgia in May of 2018. The NF Forum allows those living with NF, and their families, to connect, support, and learn from each other while attending seminars on relevant topics pertaining to neurofibromatosis. To enable closed captioning, click the CC button. To learn more about the NF Forum, go to: http://ctf.org/nfforum
Views: 63 childrenstumor
R2R Cyber Seminar (April 2013)
Part of a monthly NCI webinar series, Research to Reality, on various topics related to cancer control and prevention, this webinar explores how state/local health departments, cancer registries, academic institutions, and community organizations are collaborating to implement public health genomics programs. Presenters share experiences and offer lessons learned for others to implement similar cancer control genomics programs in their own communities.
Snowy does Vero !
Snowy gets his tail treated thanks to BrainLab at AAPM
Views: 376 lizzieread1968
Biobank Announcement
On September 25, 2010 the Caring for Carcinoid Foundation held its first Neuroendocrine Tumor Patient Education Conference at Stanford University's Alumni Center in Palo Alto California, USA. This day-long event was attended by over 100 patients and caregivers and featured neuroendocrine tumor experts from Stanford University and UCSF Medical Center. An important feature of this event was launch of Stanford Cancer Center's participation in the CFCF Neuroendocrine Tumor Bioconsortium. This Bioconsortium links the tissue biobanks at five centers which specialize in neuroendocrine tumor research and patient care. The project is a multi-institutional research program funded by Caring for Carcinoid Foundation and described in this presentation by Dr. Pamela Kunz. There was also a fundraising walk and run held the evening before the conference, which raised over $10,000 for the Bioconsortium project. To learn more, please visit www.caringforcarcinoid.org
Views: 390 Caring4Carcinoid
National Amyotrophic lateral sclerosis (ALS) Registry -- Impact, Challenges, and Future Directions
Amyotrophic lateral sclerosis (ALS), sometimes called Lou Gehrig’s disease, is a rapidly progressive, fatal neurological disease caused by degeneration of motor neurons in the brain and spinal cord. Researchers don’t know what causes ALS and there is no cure. Approximately 80 percent of persons with ALS die within 2-5 years of diagnosis. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at https://www.cdc.gov/video/phgr/2017/GR_04-18-2017.mp4
The Importance of Clinical Research for Minority and Underserved Communities
Three NCI researchers and grantees discuss how minority participation in clinical research can benefit ethnic and underserved populations. African American, Asian American, and Hispanic populations are featured.
"The Wonders of Pulses: Saving our Health and Agriculture" | Talks at Google
This panel will discuss the role of pulses in a sustainable food system as well as offer legume treats, culinary tips, and a health perspective. Learn the history of a food movement and why this is an most effective way to lower America's carbon footprint. We'll discuss the benefits of incorporating pulses and legumes to your diet - find out which pulse has more antioxidants and how easy it is to add to your culinary repertoire. Minh Tsai, Hodo Soy Beanery Liz Carlisle, Author, Lentil Underground Lawrence Kushi, Nutritional Epidemiologist, Kaiser Permanente
Views: 1688 Talks at Google
Brainlab Vision for Radiosurgery
Brainlab has been a key player in the field of precision radiotherapy and radiosurgery for over two decades. Over those twenty years, radiosurgery has moved from being a very special procedure that only a handful of institutions provided to a mainstream treatment. Patient access has improved with the large number of institutions that have adopted Linac radiosurgery. Today, 750 of the top 1000 cancer centers around the globe use Brainlab software. What is the future role of Brainlab in radiosurgery? We spent lots of time and resources on going back to the drawing board and taking a deeper look at the fundamental challenges in precision radiotherapy. How can we leverage our technology to improve the lives of patients with cancer? Watch the video to find out more or visit our radiosurgery page at http://brai.nl/B59I3073JTX
Views: 8677 Brainlab
The Lancet Oncology Commission: Future Cancer Research Priorities in the USA — Part 2
The Lancet Oncology Commission: Future Cancer Research Priorities in the USA — Part 2 Top scientists discuss how they recommend expanding and implementing the Blue Ribbon Panel’s road map for cancer research. They’ll discuss a report that will be published by the journal The Lancet Oncology and is co-edited by Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, and Chi Van Dang, M.D., Ph.D., scientific director at Ludwig Cancer Research and professor at The Wistar Institute. Visit Johns Hopkins inHealth at: https://www.hopkinsmedicine.org/inhealth
Current Management of Brain Metastasis Book
L. Dade Lunsford, MD, Lars Leksell Professor of Neurosurgery at the University of Pittsburgh, provides brief intro to guideline book.
Why your prostate cancer volumes are declining
https://www.advisory.com/Research/Oncology-Roundtable/Multimedia/Video/2015/Why-your-prostate-cancer-volumes-are-declining Prostate cancer volumes are experiencing a steep decline: according to the Florida Cancer Data System, the number of new cases fell by nearly half between 2011 and 2013. What's powering this dramatic shift, and what trends can cancer programs expect in the future? In our video, we break down data available in The Journal of the American Medical Association and explain what factors are behind the drop in prostate cancer diagnoses, from new screening guidelines to the use of active surveillance. We also talk about how these numbers will change going forward.
Views: 157 Advisory Board
Registries and Universal Screenings: Opportunities and Challenges in Various Settings
In this presentation during the February 2017 Workshop on Approaches to Blue Ribbon Panel Recommendations: The Case of Lynch Syndrome, Dr. Nancy Baxter, Dr. Noralane Lindor, Dr. Mark Jenkins, Dr. Debra Duquette, Dr. Heather Hampel, Dr. Jessica Ezzell Hunter, and Dr. Karen Lu discuss registries and universal screening, along with questions and comments from the audience. Learn more about this Workshop at https://cancercontrol.cancer.gov/lynch-syndrome-workshop/
Views: 95 NCIwebinars
Colon Cancer Under 50: Latest Update On the Numbers
While we know about the rise in this disease in those under 50, recent studies put an alarming fact into hard focus: you're never too young for colon cancer. Hematology-oncology specialist Dr. Jason Zell discusses this trend, as well as new research showing that the science behind this disease is changing. #TheAntiCancer | http://www.anti-cancer.com Get patient stories, wellness tips, health care news and more on our Live Well blog: http://www.ucirvinehealth.org/blog UC Irvine Health | http://www.ucirvinehealth.org
Views: 180 UCI Health
Dr. Damali Martin: What you should know about the grants process
Dr. Damali Martin will discuss how international researchers can navigate the NIH Grants process, including research proposal development, review process, and grant mechanism types. NCI's Center for Global Health will be including additional lectures that are geared towards international participants, especially those from low-and middle-income countries, with the goal of providing information and tools that can be used for cancer prevention and control in their home countries. The additional lectures will be presented by subject matter experts from NCI, other cancer centers and public and private organizations. To learn more, please visit http://www.cancer.gov/aboutnci/globalhealth/events.
Genome-wide association studies in Cancer: A Step in the Right Direction: Stephen Chanock
Stephen Chanock M.D. from the National Cancer Institute presents Genome-wide association studies in Cancer: A Step in the Right Direction
Views: 1151 NCIwebinars
Inside the brain lab
CBC's Chief Correspondent Peter Mansbridge goes inside the world's largest brain bank whose findings could change hockey.
Screening for Colorectal Cancer: Optimizing Quality (CME). Primary Care Version Part 1
Part 1 of the Primary Care Version CME includes basic information about colorectal cancer and screening, factors that affect when and how patients should be screened, and detailed screening and surveillance guidelines based on personal and family history. It is the first of three parts of a continuing education activity that provides guidance and tools for clinicians on the optimal ways to implement screening for colorectal cancer to help ensure that patients receive maximum benefit. For more information, visit https://www.cdc.gov/cancer/colorectal/quality/. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at https://www.cdc.gov/cancer/videos/colorectal/quality/Primary_Care1/CRC_Screening_Optimizing_Quality_Primary_Care1_lowres.mp4
R2R cyber-seminar - Expanding Lynch Syndrome Screening: From Research to Reality
Lynch syndrome (LS) is an inherited disorder that raises a person’s risk of developing colorectal, endometrial (uterine), ovarian, stomach, and other forms of cancer. Expanded screening for Lynch syndrome has been widely recommended due to the potential benefits to both patients and their family members, but has not yet been fully implemented throughout the United States. Join us for the March 21, 2017 Research to Reality cyber-seminar to learn more about Lynch syndrome, universal tumor screening, and some reflections from a National Cancer Institute hosted workshop focused on LS. David Chambers, MSc, DPhil, will give a brief overview of the webinar and provide some key takeaways from the NCI hosted workshop, ‘Approaches to Blue Ribbon Panel Recommendations: The Case of Lynch Syndrome’, convening on February 23 and 24, 2017. Heather Hampel, MS, LGC, will provide an overview of Lynch syndrome, current screening practices, and the benefits of universal tumor screening for LS. Greg Feero, MD, PhD, will discuss some of the issues that must be addressed to improve the identification and management of individuals at risk for hereditary cancer syndromes in primary care settings, and how his pilot project is approaching this issue. Debra Duquette, MS, CGC, will share ways in which the Michigan Department of Health and Human Services Cancer Genomics Program promotes awareness of and best practices surrounding Lynch syndrome. She will also describe the Lynch Syndrome Screening Network, a resource for health systems interested in implementing routine LS screening. The presenters will share their experiences working with the Lynch Syndrome Screening Network and reflect on their experiences at the NCI-hosted workshop. The final part of the webinar will offer an opportunity for participants to engage with the presenters. We encourage you to share your own experiences and thoughts! An archive of the cyber-seminar may be accessed at: https://researchtoreality.cancer.gov/cyber-seminars/expanding-lynch-syndrome-screening-research-reality
Views: 105 NCIwebinars
Clinical Trials 101
Clinical trials are research studies that involve people and test new ways to prevent, detect, diagnose, or treat cancer and other diseases. At the conclusion of this webinar, you will be able to demonstrate a basic understanding of the basics of clinical trials, including how they work, protections for participants and factors related to participation.
Views: 4246 NCIwebinars
The 2017 Jeffrey M. Trent Lecture in Cancer Research - Katherine A. Janeway
September 6, 2017 Lecture Title: Bringing Genomics to the Pediatric Oncology Clinic: Diagnosis, Treatment Selection and Rational Clinical Trial Design More: https://www.genome.gov/27568937
Genetic Testing for Neurological Diseases - Kurt Fischbeck
April 4, 2014 - The 2014-2015 Genomics in Medicine Lecture Series More: http://www.genome.gov/27556434
Welcome & Introduction to Fibrous Dysplasia
This is one of fifteen videos recorded by the Fibrous Dysplasia Foundation at the 2014 Patient and Family Conference. It was held at the NYU Langone Medical Center, New York, NY on October 25-26, 2014. Fibrous Dysplasia Foundation website: http://www.fibrousdysplasia.org Speaker Information: Charles W. Harles Charlie Harles was a founder and is now president of the Fibrous Dysplasia Foundation, established to provide information, advocacy, support, and research on FD, Mc-Cune Albright Syndrome and cherubism. Charlie was first diagnosed at age seven or eight and did not meet another person with FD/MAS until he was over 50 years old. Charlie has been participating in several studies and advocating for persons with FD and MAS at NIH. Though Charlie has had to use crutches or a wheelchair since childhood and has had many fractures and surgeries, he pursued a legal career (JD from University of North Carolina) focused on providing job training and employment for persons with disabilities. Dr. Michael Collins Dr. Collins is the Chief of the Skeletal Clinical Studies Unit at National Institutes of Health in Bethesda, Maryland. His research is focused on the study of bone biology and mineral metabolism. One of his primary foci of research is fibrous dysplasia of bone and McCune-Albright syndrome. Dr. Collins is the author of many scholarly articles on FD/MAS and has cared for more than 200 patients with FD/MAS over the last 15 years at the NIH. He has dedicated a large part of his career to advancing the understanding of FD/MAS, improving the quality of life of patients with FD/MAS through better treatments. He has been involved with the FD Foundation since its inception and serves on the Board of Medical Advisors to the Foundation.
Views: 1193 FD Foundation Inc
Vaccine Pioneer Mocked Attempting to Expose Merck - Cancer Causing Virus in Vaccine
VOICE OF DOCTOR MAURICEHILLEMAN Bill Gates And The SV40 Cancer-Causing Virus By David Jenkins 6-22-11 Read at: http://rense.com/general94/bill.htm   The new (GMO-DNA) vaccines contain SV40.   Wikipedia, in an article on DNA vaccination includes this reference to SV40:   "The SV40 promoter was conventionally used until research showed that vectors driven by the Rous Sarcoma Virus (RSV) promoter had much higher expression rates.[2] ... An example of DNA vaccine plasmid is pVAC, it uses SV40 promoter.     The SV40 Cancer Foundation, however, goes into more detail.   "SV40 was the 40th virus found in rhesus monkey kidney cells when these cells were used to make the polio vaccine. This virus contaminated both the Inactivated Polio Vaccine (IPV) created by Dr. Jonas Salk and the Oral or "Live" Polio Vaccine (OPV) created by Dr. Albert Sabin.   "In 1961, SV40 was discovered by Dr. Bernice Eddy of the National Institute of Health, Division of Biologics when she took the material used to grow polio vaccines and injected it into hamsters. Tumors grew in the hamsters. Her discovery was subsequently validated by Drs. Maurice Hilliman and Benjamin Sweet of Merck.     Children being fed sugar cubes with the oral polio vaccine. Circa 1961.   "Upon the discovery that SV40 was an animal carcinogen that had found its way into the polio vaccines, a new federal law was passed in 1961 that required that no vaccines contain this virus. However, this law did not require that SV40 contaminated vaccines be thrown away or that the contaminated seed material (used to make all polio vaccines for the next four decades) be discarded. As a result, known SV40 contaminated vaccines were injected into children up until 1963. In addition, it has been alleged that there have been SV40-contaminated batches of oral polio vaccine administered to some children until the end of the 1990's.   Dr. Robert Bell, once Vice President International Society for Cancer Research at the British Cancer Hospital said:   "The chief, if not the sole, cause of the monstrous increase in cancer has been vaccination."    Hillerman, chief of vaccines at Merck not only validated Bernice Eddy's discovery but he admitted that all Merck's vaccines contain cancer viruses and other viruses and that their Hepatitis vaccine caused the AIDS epidemic in the US.   Dr. Larry Palevsky, a NY board certified pediatrician, agrees as well that vaccines contain viruses and says that most of the viruses in vaccines can not be removed.   The new vaccines are GMO-DNA vaccines.  The material that they wish to inject has been genetically engineered (thus GMO) using parts of viruses, cancers, animal poxes, and combined, and are then shot or inhaled or injected into the body, to be "taken up by the DNA" (thus DNA) . This material is meant to affect the body in the most fundamental way possible, by affecting the very coding of the body (the DNA) which controls functions for the existence of the person.   And doesn't SV40's potential uptake by the child or adult's DNA present a much graver danger than previously?  Could this cancer virus now become part of the body's coding itself?   SV40 was removed by federal law.  So, is against federal law to introduce it into vaccines again?  And is it not an extreme threat to anyone taking the new vaccines, to have it taken up by their DNA?   Bill Gates wants every newborn on earth registered for vaccination, with cell phones to alert parents as well as locate people.     The Redmond, Wash.-based company's cofounder and chairman envisioned collecting biometric information on babies via handsets and transmitting the data to a central health registry, which could be used to remind parents about vaccinations. GPS data from the phone could also help guide medical personnel to remote locations to administer vaccines.   Continue reading at: http://rense.com/general94/bill.htm Other: SV40 CANCER FOUNDATION http://www.sv40foundation.org/CPV-link.html Transcript of audio interview with Dr. Maurice Hilleman http://www.naturalnews.com/033584_Dr_Maurice_Hilleman_SV40.html
The Lung Cancer Living Room™ - Sacramento: Expert Panel - March 2017 - Half-Hour Episode
Hear from a panel of experts in the field of lung cancer diagnosis, treatment and future advancements. Learn the importance and benefits of individualized or “precision medicine” when being treated for lung cancer. Filmed on March 23, 2017 in Sacramento, CA. Moderator: Dr. Costanzo DiPerna, MD -Dignity Health- Thoracic Surgeon Panel: Dr. Megan Daly, MD- UC Davis- Radiation Oncology Dr. Deepti Behl, MD-Sutter-Medical Oncology Dr. Peter Murphy, MD- Dignity Health- Pulmonology Rachel McConachie-Dignity Health-Nurse Navigator
Building a Cancer Program in Sub-Saharan Africa: The AMPATH-Oncology Model
Cancer has emerged as the leading cause of death in low- and middle-income countries. Many countries, especially in sub-Saharan Africa are ill prepared to handle this evolving crisis in medical care. Building on the successful collaborative partnership centered on HIV-AIDS is the AMPATH-Oncology program (the Academic Model for Providing Access to Healthcare), which is focused on enhancing the research, educational and clinical care infrastructure for western Kenya. This presentation will provide the background and current status of this ongoing experiment in health care delivery. View the other videos in this series www.cancer.gov/globalhealth/events/seminarseries
Views: 461 NCIwebinars
Pharmacogenomics - Howard McLeod (2016)
May 4, 2016 - Current Topics in Genome Analysis 2016 More: http://www.genome.gov/CTGA2016
TRACO 2014 - Ovarian cancer; Immune checkpoints
TRACO 2014 - Ovarian cancer; Immune checkpoints Air date: Monday, September 29, 2014, 4:00:00 PM Category: TRACO Runtime: 01:57:59 Description: TRACO Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in development and implementation of many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics. For more information go to http://ccr.cancer.gov/careers.courses Author: C.Annunziata; M. Merchant Permanent link: http://videocast.nih.gov/launch.asp?18646
Views: 322 nihvcast
Real Questions | Reproductive Surgery, Obstetrics and Gynecology UCLA
What is reproductive surgery? Learn more at http://obgyn.ucla.edu
Views: 306 UCLA Health
InFocus: Breast cancer awareness month
This Sunday on 22News InFocus the topic is breast cancer awareness including prevention, screenings, diagnosis, and treatment options.
Views: 65 WWLP-22News
Продукты жиросжигатели. Грейпфрут, киви, яблоки и все продукты, против жировых отложений
https://www.instagram.com/prometei.tech/ reassured screamed liter favoring traction wondered reconsider realizing plow nap brain's ebb manifests CVD HDL minutiae ducks They've sufficed proponents waged salvo yearlong Tulane coverage unanimously sarcasm Pundits predictors coffin headlines representative enrolled Asians demographic diehards implausible slashing upped group's balloons publicized uptick bioelectrical impedance predictor LDL carbers pedestrian cuttingsome glean takeaways echoed study's Lydia Bazzano compel directing dogmatic almighty Jake fascinating devoting installment I’ve mmols Wingates foggy acuity tissue's oxidize Phinney synonymous Mistaking intriguing teamed Auburn Wolfe's CPT impede trash Someone's calorically reintroduction reintroduce blunts Paoli transitioned lasted Ketostix conservatively reversals lackluster telltale stroll tantamount deluge chockfull edibles aisle Who's les courgettes serrated peeler spiralizer wonderfully hash browns mandolin dubbed cauliflower's spuds pulverize Brassica wallop Chard sauté cremini shiitake fungi umami portobello stealthily praised dearth smear firepower backlash au naturale pint shrivelled rosy orbs lycopene Nature's lengthwise microwavable parchment scrape benevolent gourd Radish Bok choy Watercress famously sang stoned sweetness tinged tipoff nondigestible plush stellar sniffles pucker Fillets mercury unseasoned marinades ante beloved deli spared lunchmeats Dijon collard fests fattened Cornish hen Gruyere mundane decoupled riff blending pinches mop cultured surging critters tangy horns cow's Brie Ricotta kefir carnivores soaks brilliantly marinate Tempeh earthy mushroomy crumbling casseroles sauerkraut Pinto boast Pepitas o castoffs Sargento stringy bathed humming lofty healthyomega shops supermarkets Pepperettes Hazelnuts Bob's fare Shirataki translucent gelatinous konjac bowlful nondescript rinse blanch Preliminary prediabetes viscous Hazelnut brewed quencher moo cartons sidestep Imbibing infuses exhaustive flapjacks marys ye sipped seltzer contradictory farther swilling interchangeably insulinogenic spur counterintuitive accessing tougher adjusts Mozzarella cucumbers kcals reservoir thriving ongoing chow insisted French's Trimmed Uncured Portabella condensed tamari aminos steamer bubbly Ruthie ours marshmallows dye pumpkins fl Truvia Nutmeg Cloves towels masher lumpy quartered ½ generously pierced family's else's cleanup cooks Kosher slits slit PDF unwrap tossed bowl's ooohs aaaahs mouthwatering Coarse wilt bakes Sprouted crumb crumbs crumble byproducts apiece appreciable granite unconditioned stepmill app Centopani eater groundbreaking world's Evan's insists com's it'd befriending fluke flounder rutabaga turnips distributing rigors regimented hamburgers Animal's flagship Pak negotiable fundamentally depleting plows wishful oversimplified depletes Karbolyn Labrada's shuttling muscles replenished proponent dragging microtraumas pounder resynthesis disposal polymer shuttle Elasti RTD MRP EFA Charge Krill MPS rapamycin hesitate Centopani's diner steakhouse wheelbarrow Overseas border nearest awful refrigeration Stak Iconic XL Beanie Rotisserie precooked breaded standby powered brothers McGrath Antoine Vaillant baggie brainer Nothing's comforting goulash Slurp swole requested dad's bursting rotini parsnips I’ll paprika Worcestershire Caraway saucepot batch Printable Frosting silicone brethren Vincenzo Masone Fritz approached days steal sanitary basa jumbo gallbladder crowns handfuls plums nectarines underconsumed drilled skulls lid poking USDA thickest translates clump cruciferous broil cardamom thankfully occasions roasting dicing drizzling facet pectin midworkout plump insides glorious skimp Tahini Cumin pretzels sing Ramen entrée zing sharpest leftover pinapple Endive chilies clove crumbles vinaigrette Kalamata pitted Oregano Bragg's tonight's Mendelsohn frothy stove fortunate micromanaging achievements NASCAR skimping mussels rabbit seitan grapefruits limes Melons honeydew apricots… chestnuts overanalyzing fistful plateauing stricter fistfuls arrangement honing afforded it'll Fiber's Satiate Yep compiled SOUTHWEST potlucks bevy ROMA SEEDED uncovered BALSAMIC yummy clocks heats PARSNIP resealable rimmed Discard FE COB THINLY spinner BURRITO RINSED GARNISHES STROGANOFF CAMPBELL'S SHERRY dente garnished Dorian coveted GROUNDED hesitation filets tenderloins scours tags grabs fattier semblance beefing thrifty exchanges D's rodeo beeline Quaker swayed canister opts canisters measly sizzling sitcom Kris EZ sec Bathe proverbial anticipate Radar Benchmarks Robergs R Pearson Costill Fink J Pascoe Benedict Zachweija intensities Calder Yaqoob Bowtell Gelly Simeoni Rennie Wang uncompromising Welsh Kage meditative yin coincides iconoclast's sellers efficaciously replicate brand's Vitargo disguise bitterness reluctantly Offerings Hydra underperforming refilming raced biked deadlifted Ironman Matt Pritchard Ironmans swears triathletes Trainee Hey faceless
Views: 51265 ПРОКАЧКА
INSIGHTS ON PBS HAWAII - Should Hawaii Require All Children to Be Vaccinated?
Measles outbreaks linked to unvaccinated children on the mainland have many in Hawaii questioning whether our vaccination requirements are strong enough to prevent an outbreak here. Although several vaccinations are required to attend public schools, parents who believe the shots are dangerous or unnecessary can seek exemptions for religious and medical reasons. But now that the nearly eradicated measles virus has returned, should exemptions for healthy children still be allowed? Malia Mattoch moderates this discussion.
Views: 6877 PBSHawaiiorg
About Patient Centered Outcomes Research (PCOR/PCORI)
Speaker: Vanessa Merker, BS, Massachusetts General Hospital. This is an original presentation from the Children's Tumor Foundation. 2018 NF Forum that took place in Atlanta, Georgia in May of 2018. The NF Forum allows those living with NF, and their families, to connect, support, and learn from each other while attending seminars on relevant topics pertaining to neurofibromatosis. To enable closed captioning, click the CC button. To learn more about the NF Forum, go to: http://ctf.org/nfforum
Views: 14 childrenstumor